|
|
|
|
|
|
|
 |
Funded by the European Commission
 Marie Curie Actions ITN FP7 PEOPLE |
 Partners Queen Mary, University of London School of Biology and Chemical Sciences Microgel and nanogel synthesis, design synthesis and characterisation of functional monomers. Queen Mary, University of London Blizard Institute of Cell and Molecular Science Genetics, cell culture, histology and dermatology at research and clinical level. Centre National de Recherche Scientifique Nanobiotechnology, nanomaterials and nanocharacterisation, and analytical chemistry. Sanofi-Aventis Structure Design and Informatics Computational chemistry, computer simulations, quantum chemical calculations. Sanofi-Aventis Advanced Research In vitro and in vivo imaging, Cellular Biology, Molecular Pharmacology. Universitaet Innsbruck Institut für Allgemeine, Anorganische und Theoretische Chemie Molecular modelling, computer simulations, chemoinformatics, quantum-mechanics. Cranfield University Institute of Environment health, Cranfield Health In vitro toxicity studies. Coimbra University Centre of Neuroscience and Cell Biology Bioavailability, toxicology, drug release. MJRPharmJet Design of experiments and its applications in Quality by Design, nanoparticle design and fabrication for drug delivery. Université Catholique de Louvain Nanomedicine, Topical drug bioavailability, Transdermal drug delivery, Ethical aspects associated with in-vivo and animal experiments. Associated Partners Transdermic In vivo studies of siRNA efficacy including delivery technologies, education and training. Institute of Nanotechnology Risk management, regulations, environment. University of California and Irvine School of Physical Sciences Nanoparticle synthesis, polymer synthesis, organic synthesis, hybrid materials All partners Professional training in nanomedicine, career and personal development, European integration.  |
||
| Partners | ||
| Researchers | ||
 |
Expertise | |
  |
||
 |